New hope for high cholesterol: Statin-Free drug shows promise in Year-Long study

NCT ID NCT05687071

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a daily pill called ETC-1002 in 130 adults with very high LDL ("bad") cholesterol who either didn't respond well to statins or had side effects from them. Over 52 weeks, researchers checked how safe the drug was and how much it lowered cholesterol. The goal was to see if this drug could be a long-term option for managing cholesterol when statins aren't suitable.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HYPER-LDL CHOLESTEROLEMIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Rinku General Medical Center

    Izumisano, Japan